Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 175 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
1741 N/R Advanced Ovarian cancer 4 Biologic therapy
Stanford University Medical Center United States 1/2004
Treatment Details: Patients: This phase II study involved 36 women with advanced ovarian cancer. The median age was 57. Treatment: The treatment involved one biological agent - an antisense oligonucleotide
 
1742 N/R Recurrent Ovarian cancer 3 Biologic therapy
Christie Hospital NHS Trust United Kingdom 10/2003
Treatment Details: Patients: This phase II study involved 11 women with recurrent epithelial ovarian cancer. Treatment: The treatment consisted of a biological agent called bryoststin-1. Bryostatin-1 is a
 
1743 N/R Relapsed Ovarian cancer 3 Biologic therapy
National Cancer Institute United States 12/2003
Treatment Details: Patients: This phase II study involved 36 patients with relapsed epithelial ovarian cancer. Treatment: The treatment involved one biologic agent called carboxyamidotriazole (CAI). CAI is
 
1744 N/R Hormone refractory prostate cancer 3 Chemotherapy
Princess Margaret Hospital Canada 9/2005
Treatment Details: Patients: This Phase II study involved 40 men with hormone resistent prostate cancer. 21 patients had prior radiation therapy and 26 had prior hormone therapy. Metastatic sites included bon
 
1745 N/R Metastatic renal cell carcinoma 3 Chemotherapy
Memorial Sloan-Kettering Cancer Center United States 8/2002
Treatment Details: Patients: This Phase II trial involved 14 patients with metastatic renal cell carcinoma, 7 men and 7 women. The median age was 55 and 8 had undergone prior nephrectomy. Treatment: The tr
 
1746 N/R Advanced renal cancer 4 Biologic therapy
Churchill Hospital United Kingdom 10/2003
Treatment Details: Patients: This Phase II study involved 16 patients with advanced renal cancer; 11 men and 5 women. Median age was 59. Eight had undergone prior nephrectomy. Most had undergone other previ
 
1747 N/R Metastatic renal cell carcinoma 3 Immunotherapy
University of Washington United States 9/2003
Treatment Details: Patients: This Phase I study involved 26 patients with metastatic renal cell carcinoma; 19 men and 7 women. Median age was 58. Sites of metastasis included bone, liver, lung, lymph nodes,
 
1748 N/R Metastatic renal cell carcinoma 4 Biologic therapy
Memorial Sloan-Kettering Cancer Center United States 2/2003
Treatment Details: Patients: This Phase II study involved 54 patients with metastatic renal cell carcinoma; 44 men and 10 women. The average age was 59. Thirty-seven patients had undergone a prior nephrectom
 
1749 N/R Advanced breast cancer 3 Biologic therapy
Johns Hopkins Oncology Center United States 10/2001
Treatment Details: Patients: This Phase I study involved a total of 27 patients with solid malignancies. Six patients had advanced breast cancer. Treatment: Treatment consisted of an inhibitor (BAY12-9566
 
1750 N/R Metastatic breast cancer 2 Biologic therapy
Churchill Hospital United Kingdom 3/1999
Treatment Details: Patients: This Phase II study involved 14 women with metastatic breast cancer. Median age was 58.5. Prior treatments included endocrine (13 patients), chemotherapy (12 patients), and radia
 
Page 175 of 187  | Previous Page  | Next Page